Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-11

FDA Approved: DALFAMPRIDINE — Original Application (Micro Labs Limited)

View source ↗

Summary

FDA approved dalfampridine under an Original Application for Micro Labs Limited. The drug is intended to improve walking in adults with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dalfampridine (dalfampridine)

Snippet

ORIG AP for DALFAMPRIDINE (DALFAMPRIDINE)